Goeltz II Robert C.
Arcus Biosciences, Inc. · Chief Financial Officer
Goeltz II Robert C. is listed in filings as Chief Financial Officer at Arcus Biosciences, Inc.. This profile follows SEC Form 4 activity through May 12, 2026, including sale activity. Recent filings connect the profile to Arcus Biosciences, Inc. (RCUS). The current snapshot covers public activity from Dec 17, 2024 to May 12, 2026. Reported amounts are shown as $199.0K to $153.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $153k6.6k shares | SellDec 31, 2025 | $23.38 | $26.64 | |
| $132k6k shares | SellDec 17, 2025 | $22.16 | $26.64 | |
| $147k6.7k shares | SellDec 16, 2025 | $21.88 | $26.64 | |
| $125k5k shares | SellNov 26, 2025 | $25.00 | $26.64 | |
| $100k5k shares | SellOct 28, 2025 | $20.00 | $26.64 | |
| $54k3.6k shares | SellDec 31, 2024 | $15.00 | $26.64 |